Literature DB >> 8244774

Ultrastructural organization of type XI collagen in fetal bovine epiphyseal cartilage.

B Petit1, M C Ronzière, D J Hartmann, D Herbage.   

Abstract

Type XI collagen was localized with polyclonal antibodies specific for alpha 1 (XI) and alpha 2 (XI) chains in the resting zone of epiphyseal cartilage from calf fetuses. The immunofluorescence technique was used on sections of cartilage, and the immunogold labelling technique for electron microscopy on fibrils isolated from cartilage and, for the first time, in situ on blocks of cartilage fractured in liquid nitrogen. Immunofluorescence showed that without pepsin treatment the staining of type XI collagen was restricted to the pericellular zones; after pepsin treatment, the staining was co-distributed with that of type II collagen. Immunoelectron microscopy performed on isolated fibrils and on cartilage blocks showed that after disruption of fibrils with pepsin, type XI collagen was labelled on small filaments on the fibrils. When the fibrils were not disrupted, labelling was observed in situ only at the ends of the fibrils or on cross-sections of some fibrils. These results indicate that type XI collagen is located inside type II collagen fibrils in fetal bovine epiphyseal cartilage, as already postulated for embryonic chicken sterna.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8244774     DOI: 10.1007/bf00269096

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  30 in total

1.  The human rhabdomyosarcoma cell line A204 lays down a highly insoluble matrix composed mainly of alpha 1 type-XI and alpha 2 type-V collagen chains.

Authors:  J P Kleman; D J Hartmann; F Ramirez; M van der Rest
Journal:  Eur J Biochem       Date:  1992-11-15

Review 2.  The contribution of collagenous proteins to tissue-specific matrix assemblies.

Authors:  M K Gordon; B R Olsen
Journal:  Curr Opin Cell Biol       Date:  1990-10       Impact factor: 8.382

3.  The cartilage collagens: structural and metabolic studies.

Authors:  D R Eyre; J J Wu; P E Woods
Journal:  J Rheumatol Suppl       Date:  1991-02

4.  Type IX collagen proteoglycan from cartilage is covalently cross-linked to type II collagen.

Authors:  M van der Rest; R Mayne
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

5.  Localisation of collagen types and fibronectin in cartilage by immunofluorescence.

Authors:  H B Evans; S Ayad; M Z Abedin; S Hopkins; K Morgan; K W Walton; J B Weiss; P J Holt
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

6.  Problems in the immunolocalization of type IX collagen in fetal calf cartilage using a monoclonal antibody.

Authors:  J Vilamitjana; A Barge; A K Julliard; D Herbage; T Baltz; R Garrone; M F Harmand
Journal:  Connect Tissue Res       Date:  1989       Impact factor: 3.417

7.  Cloning and sequencing of pro-alpha 1 (XI) collagen cDNA demonstrates that type XI belongs to the fibrillar class of collagens and reveals that the expression of the gene is not restricted to cartilagenous tissue.

Authors:  M Bernard; H Yoshioka; E Rodriguez; M Van der Rest; T Kimura; Y Ninomiya; B R Olsen; F Ramirez
Journal:  J Biol Chem       Date:  1988-11-15       Impact factor: 5.157

8.  Comparative structural studies of reconstituted and native type I and type II collagen fibrils by low-angle X-ray diffraction.

Authors:  M C Ronzière; C Berthet-Colominas; D Herbage
Journal:  Biochim Biophys Acta       Date:  1987-12-18

9.  D-periodic distribution of collagen type IX along cartilage fibrils.

Authors:  L Vaughan; M Mendler; S Huber; P Bruckner; K H Winterhalter; M I Irwin; R Mayne
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

10.  Cellular heterogeneity in cultured human chondrocytes identified by antibodies specific for alpha 2(XI) collagen chains.

Authors:  B Swoboda; R Holmdahl; H Stöss; K von der Mark
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539

View more
  8 in total

1.  On the ultrastructure of softened cartilage: a possible model for structural transformation.

Authors:  M H Chen; N Broom
Journal:  J Anat       Date:  1998-04       Impact factor: 2.610

2.  The development of articular cartilage: I. The spatial and temporal patterns of collagen types.

Authors:  E H Morrison; M W Ferguson; M T Bayliss; C W Archer
Journal:  J Anat       Date:  1996-08       Impact factor: 2.610

3.  A Krüppel-associated box-zinc finger protein, NT2, represses cell-type-specific promoter activity of the alpha 2(XI) collagen gene.

Authors:  Kazuhiro Tanaka; Noriyuki Tsumaki; Christine A Kozak; Yoshihiro Matsumoto; Fumihiko Nakatani; Yukihide Iwamoto; Yoshihiko Yamada
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

4.  Changes in type II procollagen isoform expression during chondrogenesis by disruption of an alternative 5' splice site within Col2a1 exon 2.

Authors:  Thomas M Hering; Louisa Wirthlin; Soumya Ravindran; Audrey McAlinden
Journal:  Matrix Biol       Date:  2014-04-13       Impact factor: 11.583

Review 5.  Alternative splicing of type II procollagen: IIB or not IIB?

Authors:  Audrey McAlinden
Journal:  Connect Tissue Res       Date:  2014-04-18       Impact factor: 3.417

6.  Reduction of type V collagen using a dominant-negative strategy alters the regulation of fibrillogenesis and results in the loss of corneal-specific fibril morphology.

Authors:  J K Marchant; R A Hahn; T F Linsenmayer; D E Birk
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

7.  Separable cis-regulatory elements that contribute to tissue- and site-specific alpha 2(XI) collagen gene expression in the embryonic mouse cartilage.

Authors:  N Tsumaki; T Kimura; Y Matsui; K Nakata; T Ochi
Journal:  J Cell Biol       Date:  1996-09       Impact factor: 10.539

8.  Achilles and tail tendons of perlecan exon 3 null heparan sulphate deficient mice display surprising improvement in tendon tensile properties and altered collagen fibril organisation compared to C57BL/6 wild type mice.

Authors:  Cindy C Shu; Margaret M Smith; Richard C Appleyard; Christopher B Little; James Melrose
Journal:  PeerJ       Date:  2018-06-29       Impact factor: 2.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.